Skip to main content
Premium Trial:

Request an Annual Quote

Crescendo Receives CAP Accreditation for CLIA Lab

Premium

Crescendo Bioscience said this week that it has received accreditation for its laboratory from the Commission on Laboratory Accreditation of the College of American Pathologists.

The accreditation offers further validation of the company's CLIA lab facility and its 12 protein Vectra DA test that it runs out of that facility, William Hagstrom, Crescendo's president and CEO said in a statement.

CAP accreditation involves examination of a laboratory’s records and quality control procedures for the preceding two years as well as examination of staff qualifications, laboratory equipment, safety programs and records, and overall laboratory management.

The U.S. government recognizes the CAP Laboratory Accreditation Program as being equal-to or more-stringent-than the government’s own inspection program, Crescendo said.

The CAP accreditation follows Crescendo's receipt in April of approval for its CLIA lab from the New York Department of Health's Clinical Laboratory Evaluation Program. With that approval, Vectra DA is now available in all 50 states.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more